The ISN has carried out several projects under the CKD Closing the Gaps Initiative:
Critical gaps in knowledge of the prevalence and incidence of chronic kidney disease (CKD) and existing care structures are affecting global healthcare planning for patients.
The ISN Global Kidney Health Atlas (GKHA) gives a comparative analysis and data synthesis of CKD trends and the consequences of its burden worldwide. It raises awareness of the causes of CKD, identifying gaps modeled on the Universal Health Coverage (UHC) domains to build the foundations for a global CKD care surveillance network.
Discover more and access the GKHA reports on the GKHA homepage.
First Global Kidney Health Summit
85 international key opinion leaders and researchers met for two and a half days in July 2016, in Vancouver, BC, Canada to set in motion a roadmap for action to change the status of kidney health worldwide, building on current knowledge, research, and clinical activities.
The summit addressed CKD issues of global relevance. In the context of the ISN-GKHA, the connection between CKD and AKI was discussed as well as the link between kidney disease and cardiovascular and metabolic disorders.
The road map stemming from these discussions was published in The Lancet. It identifies and prioritizes key activities for the next 5–10 years in clinical care, research, and advocacy, and proposes an action plan and performance framework based on ten themes.
In partnership with the Mexican Ministry of Health and with the participation of The Lancet, on 21 April 2017, ISN brought together high-level decision-makers and stakeholders to address the burden of kidney disease in the Americas region and share strategies for prevention and improved management of the disease at both regional and global levels. Participants included representatives from national health ministries, international and local health organizations, key opinion leaders, and representatives of the wider health community.
The Conclusions of Mexico City (in Spanish), a 12-point set of measurable actions to curb the burden of kidney disease worldwide, specifically focusing on Latin America, was established to be endorsed by participants.
Also available in English, the conclusions call for key measures aimed at developing and implementing integrated non-communicable disease programs addressing CKD risk factors; implementing and supporting surveillance mechanisms such as robust national and regional registries for AKI, CKD, and kidney failure; and crucially ensuring just and equitable access to kidney disease care, including dialysis and transplantation.
For more information about the outcome of the first Policy Forum, please click here.
The Global Kidney Policy Forum was the first in a series of yearly high-level ISN Policy Forum meetings organized by the ISN at each World Congress of Nephrology (WCN). This innovative format provides an opportunity to bring an international viewpoint to key issues related to the prevention and management of kidney disease impacting a particular country or region.
The first meeting culminated in a clear call for action to national, regional, and global policymakers. Read it below in English or Spanish:
On World Kidney Day (WKD) 2016, the ISN and The Lancet launched The Lancet Kidney Campaign to raise awareness of acute and chronic kidney diseases and to bring together the best available evidence to inform strategies to reduce the national, regional, and global burden of kidney disease and its risk factors.
The Campaign built on the ISN’s 2015 Lancet Commission, which amplified ISN’s call for the elimination of preventable deaths from AKI by 2025. It contributed to and reinforced the Policy Forum at the WCN in 2017, where participants endorsed the Conclusions of Mexico City, a 12-point set of actions to curb the burden of kidney disease worldwide.
Hosted on The Lancet website, the Campaign brings together research and analysis on AKI, CKD, and dialysis and transplantation from across the journal’s database. Over 22 months, it provided monthly updates on advances in nephrology as well as expert commentaries and interviews on key health and policy issues relevant to kidney disease. By the Campaign’s end in January 2018, a full complement of 33 updates was published.
Eight key society partners (SLANH, ISPD, IPNA, TTS, IFKF, APSN, ISHD, ERA-EDTA) formally joined the Campaign in 2016, and each society contributed an update to the Campaign. Thanks to this increased exposure, the Campaign website was visited over 21,500 times over 22 months, and the Campaign updates count over 9,300 reads.